— Know what they know.
Not Investment Advice

CLPT NASDAQ

ClearPoint Neuro, Inc.
1W: -8.4% 1M: +6.5% 3M: -17.3% YTD: -16.6% 1Y: -8.5% 3Y: +33.4% 5Y: -35.3%
$11.44
-0.26 (-2.22%)
 
Weekly Expected Move ±11.9%
$9 $10 $12 $13 $14
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 60 · $343.1M mcap · 25M float · 2.96% daily turnover · Short 60% of daily vol

📊 Key Metrics

TTM
$41M
Revenue
+26.0% YoY
$-29M
Net Income
-39.8% YoY
$-27M
Free Cash Flow
-127.5% YoY
62.2%
Gross Margin
-69.9%
Op. Margin
-78.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-108.8%
ROA-42.5%
ROIC-51.9%

Valuation

P/E-11.8
P/B18.2
EV/EBITDA-11.7

Leverage

Debt/Equity2.08
Current Ratio5.91
Interest Cov.-9.8x

Quality Scores

Piotroski F5/9
Altman Z-0.63
Beneish M2.68

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms